Article: New Research From the Institute of Psychiatry Links Schizophrenia and Alzheimer's Disease.

LONDON, March 13 /PRNewswire/ --

Research from the Institute of Psychiatry, London, that offers a radical new approach to treating schizophrenia has received a substantial grant from the Stanley Foundation, a major mental health charity based in the United States. The new study developed by Dr. Tonmoy Sharma and his team involves giving an Alzheimer's drug for one year to people with schizophrenia.

Schizophrenia is best known for its so-called positive symptoms such as hallucinations or delusions. But cognitive difficulties - such as problems with memory, attention and decision making - are thought to be core and enduring features of schizophrenia. It is ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!